We value your privacy We use cookies to analyze site traffic and improve your experience. See our Privacy Policy . Latest updates in drug development and regulatory affairs Kelley Wolf Reveals 'Breakthrough Drug-Induced Mania with Psychosis' Diagnosis One Year After Mental Health Crisis Kelley Wolf publicly disclosed a diagnosis of "breakthrough drug-induced mania with psychosis," which she attributed to a combination of stress, past trauma, hormonal changes, hallucinogens, and prescription medications. Atorvastatin cuts major cardiovascular events by 30% in healthy adults over 70, STAREE trial finds The STAREE trial showed atorvastatin 40 mg daily reduced major cardiovascular events by 30% versus placebo in adults aged 70 and older without known cardiovascular disease, diabetes, or dementia. FDA Approves MIMRYLO (rusfertide), First-in-Class Hepcidin Mimetic for Polycythemia Vera The U.S. FDA approved Takeda's MIMRYLO (rusfertide), a first-in-class hepcidin mimetic, for treating erythrocytosis in adults with polycythemia vera (PV), a blood cancer. Browse by Angle Regulatory & Approvals Agency reviews, approvals, clearances, and exclusivity milestones. Chimpanzees Once Used in Hepatitis B Vaccine Research Receive Long-Term Health Checks in Liberia Defence Therapeutics Receives First Settlement Under Sharing Agreement with Sorbie Bornholm Trials & Research Clinical milestones, study design, topline data, and research signals. Singapore Bets $350 Million on Geroscience to Extend Healthspan Nationwide Pemi Launches Women's Daily Supplement Routine Built Specifically for Perimenopause Voice Disorders May Be an Earlier, Stronger Sign of Dementia Than Hearing Loss, Large Study Finds Deals & Company Moves Partnerships, financings, restructurings, and leadership changes. Nigerian Army Pursues Public-Private Partnerships to Modernise Military Healthcare Facilities Evinova and Lothar Medical Partner to Modernise Respiratory Clinical Trials with Unified Digital Solution CDC Withholds Pennsylvania's Measles Deaths From National Dashboard Amid Political Standoff Chimpanzees Once Used in Hepatitis B Vaccine Research Receive Long-Term Health Checks in Liberia A group of West African chimpanzees formerly used in hepatitis B vaccine experiments has received comprehensive health checks at a sanctuary in Liberia. Nigerian Army Pursues Public-Private Partnerships to Modernise Military Healthcare Facilities The Nigerian Army, led by Chief of Army Staff Lieutenant General Waidi Shaibu, is exploring public-private partnerships to modernise its healthcare facilities and infrastructure.

Singapore Bets $350 Million on Geroscience to Extend Healthspan Nationwide Singapore launched a $350 million healthy longevity grand challenge in May 2026 under its RIE2030 framework to extend healthspan and shorten years lived in poor health. Longview Passes Ordinance Criminalizing Child Exposure to Schedule I and II Controlled Substances The Longview City Council passed Ordinance 3579 by a 6-1 vote, making it a gross misdemeanor for adults to expose children to Schedule I and II controlled substances. Evinova and Lothar Medical Partner to Modernise Respiratory Clinical Trials with Unified Digital Solution Evinova and Lothar Medical announced a strategic partnership to integrate Evinova's Unified Trial Solution with Lothar Medical's three-in-one respiratory diagnostic devices. Pemi Launches Women's Daily Supplement Routine Built Specifically for Perimenopause Pemi, a women-founded wellness brand, launched with three oral dissolving supplement strips targeting mood, mental clarity, and sleep during perimenopause. Voice Disorders May Be an Earlier, Stronger Sign of Dementia Than Hearing Loss, Large Study Finds A study of 833,417 patients found that people with a voice disorder but no hearing loss were 58% more likely to develop cognitive impairment or dementia than those with neither condition. Defence Therapeutics Receives First Settlement Under Sharing Agreement with Sorbie Bornholm Defence Therapeutics completed a non-brokered private placement on March 6, 2026, issuing 17,445,455 units at $0.55 per unit for gross proceeds of $9,595,000.25. CDC Withholds Pennsylvania's Measles Deaths From National Dashboard Amid Political Standoff The CDC's latest national measles update continues to omit two measles-related deaths reported by Pennsylvania, marking an unusual break from standard disease-surveillance procedure. Novartis' pelacarsen misses primary endpoint in Lp(a)HORIZON Phase III cardiovascular outcomes trial The Phase III Lp(a)HORIZON trial of pelacarsen did not meet its primary endpoint of reducing the composite risk of cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, and urgent coronary revascularization requiring hospitalization compared to placebo. Top Stories This Week Kelley Wolf Reveals 'Breakthrough Drug-Induced Mania with Psychosis' Diagnosis One Year After Mental Health Crisis Atorvastatin cuts major cardiovascular events by 30% in healthy adults over 70, STAREE trial finds FDA Approves MIMRYLO (rusfertide), First-in-Class Hepcidin Mimetic for Polycythemia Vera Dutch Drug Institute Issues Red Alert Over Potentially Fatal Trump-Shaped Ecstasy Pills Containing PMMA REACT Study: Early Imaging Detects Silent Atherosclerosis Missed by Conventional Risk Assessment Novartis, Bristol Myers pause autoimmune CAR-T trials after inflammatory safety signals Australia Expands PBS Subsidy for Keytruda to Cover Ovarian, Bile Duct and Merkel Cell Cancers Superluminal Medicines Raises $60M Series B to Advance MC4R Agonist for Rare Genetic Obesity into the Clinic UBS Lifts J&J Price Target to $320 on Oncology and Immunology Growth Outlook Inventiva Appoints Chris Benecchi as Chief Operating Officer Ahead of Pivotal MASH Phase 3 Readout Get a weekly summary of the top clinical trial and drug development news delivered to your inbox.